Salomon & Ludwin
EW icon

Salomon & Ludwin’s Edwards Lifesciences EW Stock Holding History

Salomon & Ludwin’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.2K Hold
141
– – ﹤0.01% 1243
2026
Q2 		$13K Sell
141
-1
-0.7% -$84 ﹤0.01% 1464
2026
Q1 		$11.5K Hold
142
– – ﹤0.01% 1454
2025
Q4 		$12K Sell
142
-42
-23% -$3.45K ﹤0.01% 1327
2025
Q3 		$14.2K Buy
+184
New +$14.4K ﹤0.01% 1046

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return

Salomon & Ludwin's EW Position: Q3 2026 in Review

Salomon & Ludwin held its Edwards Lifesciences (EW) position steady in Q3 2026 at 141 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Salomon & Ludwin first reported a position in EW in Q3 2025 and has held it in 5 quarters since. The position peaked at $14.2K in Q3 2025. 851 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Salomon & Ludwin held 141 shares of Edwards Lifesciences worth $12.2K as of Q3 2026.
  • Salomon & Ludwin left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1243 holding.
  • Salomon & Ludwin first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's Edwards Lifesciences position peaked at $14.2K in Q3 2025.
  • 851 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.